- cross-posted to:
- health@lemmy.world
- cross-posted to:
- health@lemmy.world
CVS is revamping the way it reimburses its pharmacies for prescription medications, a move that could make prescription drug pricing simpler and change how much consumers pay for their medicines.
The company said in an announcement Tuesday that its new pharmacy reimbursement model will bring more transparency to its drug pricing system. It’s a similar model to the one entrepreneur Mark Cuban is pushing with his Cost Plus Drugs company.
Currently, the prices customers pay for drugs and the payments pharmacies receive are largely determined by middlemen known as pharmacy benefit managers, which negotiate rebates from drug manufacturers to insurers. These complex reimbursement formulas aren’t directly based on what pharmacies spent to purchase specific drugs.
Nope. In a bizarre twist, pharmacies PAY for the privilege of using a discount card to make your med cheaper. GoodRx charges the most that I am aware of, but these payments can be like $1-$7 paid to the coupon provider. The reason is, GoodRx advertised the lowest price they would accept to you, so they paid GoodRx for the advertisement that brought you in. While you are in they hope to make a profit in other ways, and may also be making a small profit still, despite the apparent 90% markdown.
The reason they cannot discount without the card is because they must have a “usual and customary” charge to start the negotiations with when they determine how much the insurance companies will pay. If they just discounted willy nilly, that would make the charge they started with wrong, which could be considered fraudulently representing their pricing.
Healthcare in America guys. It makes sense. Trust me, no better way could possibly be constructed.
Yes, but they’ve also sold the data in the past.
Glad to see the FTC take up this fight in any case.